Melanoma News and Research

Latest Melanoma News and Research

Exploring the links between chronic stress, inflammation and depression

Chronic stress can inflame our brain, destroy the connections between our neurons and result in depression, scientists say.

21 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

New drug combo may improve pancreatic cancer therapy

A new study by scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a combination of two cancer-fighting drugs that successfully worked on pancreatic tumor in mice, shrinking them significantly, and paving the way for a speedy clinical trial designed to test their efficacy in humans.

18 Nov 2019

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

The overall rate of new cancer cases is decreasing in men but increasing in women younger than 80 years, and obesity-related cancers are increasing in young people, according to a study on cancer trends in Canada from 1971 to 2015 published in CMAJ (Canadian Medical Association).

18 Nov 2019

Promising method to identify aggressive breast cancers that will respond to immunotherapy

University of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a promising method to identify aggressive breast cancer tumors that will respond to drugs that unleash the immune system against cancer.

14 Nov 2019

Knocking out 'survival system' of cancer cells could improve effectiveness of melanoma treatment

The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the 'survival system' of cancer cells according to a study published in Nature Communications today.

14 Nov 2019

Melanoma rates decline sharply among adolescents and young adults, shows research

Cases of melanoma among U.S. adolescents and young adults declined markedly from 2006 to 2015 - even as the skin cancer's incidence continued to increase among older adults and the general population during the span, new research shows.

13 Nov 2019

Campaigns promoting sun-protective behaviors seem to be working in the US

Public health programs designed to promote sun-protective behaviors seem to be gaining traction in the United States.

13 Nov 2019

First comprehensive characterization of blood-brain, blood-tumor barriers in brain metastases

The human brain has some remarkable capabilities - including the ability to block cancer drugs from effectively reaching cancer cells in the brain.

12 Nov 2019

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

11 Nov 2019

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable and highly active anti-tumor T cells.

10 Nov 2019

Scientists discover role for vitamin D in melanoma

A new study published in Cancer Research suggests that high levels of vitamin D may reduce the aggressive nature of melanoma cells and improve survival rates.

8 Nov 2019

Cancer risk reduces to half with over 20% weight loss in post- bariatric surgery patients

Patients with severe obesity who had bariatric or weight-loss surgery and lost more than 20% of their total weight were 50% less likely to develop cancer compared to patients who did not have as much weight loss after surgery, according to a new study presented today by Oregon Health & Science University researchers at the 36th American Society for Metabolic and Bariatric Surgery Annual Meeting at ObesityWeek 2019.

5 Nov 2019

Melanoma News and Research

Latest Melanoma News and Research

Exploring the links between chronic stress, inflammation and depression

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New drug combo may improve pancreatic cancer therapy

Study explores the overall rate of new cancer cases in Canada from 1971 to 2015

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Knocking out 'survival system' of cancer cells could improve effectiveness of melanoma treatment

Melanoma rates decline sharply among adolescents and young adults, shows research

Campaigns promoting sun-protective behaviors seem to be working in the US

First comprehensive characterization of blood-brain, blood-tumor barriers in brain metastases

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

Scientists discover role for vitamin D in melanoma

Cancer risk reduces to half with over 20% weight loss in post- bariatric surgery patients

ISPOR explores digital health technologies to address key health-related challenges

Some skin cancers originate in hair follicles, says new study

Some deadly skin cancers may originate in hair follicles

Some skin cancers may originate in hair follicles

Moffitt study discovers cellular mechanism controlling tumor cell recognition by immune cells

Scientists visualize complex cellular machine to yield new insights in cancer

Skin cancer diagnosis using AI technology could be as accurate as clinical specialist

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Melanoma News and Research

Latest Melanoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in